Lord, Abbett & Co’s Globus Medical GMED Stock Holding History

Lord, Abbett & Co’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.7M	Sell	261,901 -996	-0.4%	-$84.7K	0.06%	301
2026 Q1	$22.7M	Sell	262,897 -5,664	-2%	-$508K	0.07%	258
2025 Q4	$23.4M	Sell	268,561 -57,365	-18%	-$4.35M	0.07%	262
2025 Q3	$18.7M	Sell	325,926 -24,903	-7%	-$1.43M	0.06%	297
2025 Q2	$20.7M	Sell	350,829 -229,032	-39%	-$14.8M	0.07%	281
2025 Q1	$42.4M	Sell	579,861 -115,815	-17%	-$9.57M	0.15%	170
2024 Q4	$57.5M	Buy	695,676 +165,225	+31%	+$13M	0.18%	150
2024 Q3	$37.9M	Buy	+530,451	New	+$37.4M	0.12%	207
2023 Q4	–	Sell	-6,429	Closed	-$319K	–	546
2023 Q3	$319K	Buy	+6,429	New	+$359K	﹤0.01%	524
2014 Q3	–	Sell	-1,039,105	Closed	-$24.9M	–	993
2014 Q2	$24.9M	Sell	1,039,105 -642,527	-38%	-$15.5M	0.06%	472
2014 Q1	$44.7M	Buy	+1,681,632	New	+$40M	0.1%	308

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Lord, Abbett & Co's GMED Position: Q2 2026 in Review

Lord, Abbett & Co reduced its Globus Medical (GMED) stake by 0.38% in Q2 2026, selling an estimated $84.7K and leaving 261,901 shares worth $20.7M. The position accounts for 0.06% of the portfolio, ranked #301.

Lord, Abbett & Co first reported a position in GMED in Q1 2014 and has held it in 11 quarters since. The position peaked at $57.5M in Q4 2024. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Lord, Abbett & Co held 261,901 shares of Globus Medical worth $20.7M as of Q2 2026.
Lord, Abbett & Co sold 996 Globus Medical shares in Q2 2026, an estimated $84.7K.
Globus Medical made up 0.06% of Lord, Abbett & Co's portfolio in Q2 2026, its #301 holding.
Lord, Abbett & Co first reported a position in Globus Medical in Q1 2014 and has held it in 11 quarters since.
Lord, Abbett & Co's Globus Medical position peaked at $57.5M in Q4 2024.
599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Lord, Abbett & Co's 13F filing for Q2 2026, filed 14 Aug 2026.